Qaradakhi Tawar, Apostolopoulos Vasso, Zulli Anthony
Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Werribee Campus, 3030 Victoria, Australia.
Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Werribee Campus, 3030 Victoria, Australia.
Pharmacol Res. 2016 Sep;111:820-826. doi: 10.1016/j.phrs.2016.07.025. Epub 2016 Jul 22.
A primary peptide of the renin angiotensin system (RAS), Angiotensin (Ang) II, is a vasoconstrictor and promotor of atherosclerosis. To counter this, the RAS also consists of peptides and receptors which increase nitric oxide release from the endothelium and decrease nicotinamide adenine dinucleotide phosphate oxidase-related superoxide production. Two peptides, Ang (1-7) and alamandine are vasodilators, by activating the nitric oxide pathway via different receptors in the endothelium. Thus, herein we focus on the similarities and differences between alamandine and Ang (1-7) and the counterbalancing hypothesis on Ang II during endothelial dysfunction and atherosclerosis.
肾素血管紧张素系统(RAS)的主要肽类物质血管紧张素(Ang)II是一种血管收缩剂和动脉粥样硬化促进剂。与之相反,RAS还包括一些肽类和受体,它们可增加内皮细胞释放一氧化氮,并减少烟酰胺腺嘌呤二核苷酸磷酸氧化酶相关的超氧化物生成。两种肽类物质,即Ang(1-7)和阿拉曼丁,可通过激活内皮细胞中不同的受体,经由一氧化氮途径发挥血管舒张作用。因此,本文我们将重点关注阿拉曼丁与Ang(1-7)之间的异同,以及在内皮功能障碍和动脉粥样硬化过程中关于Ang II的平衡假说。